Landai Technology Group Corp., a subsidiary, is planning to sell assets related to the assembly of electric drive units for a total of 110 million yuan.
Blue Dye Technology (002765.SZ) announced that its wholly-owned subsidiary, Ma'anshan Blue Dye Transmission Machinery Co., Ltd., intends to...
Landai Technology Group Corp., (002765.SZ) announced that its wholly-owned subsidiary, Ma'anshan Landai Transmission Machinery Co., Ltd., intends to transfer the assets related to the assembly business of electric drive units located at 199 Longshan Road, Ma'anshan Economic and Technological Development Zone, and the necessary rights and interests for the continuous operation of the aforementioned business to Luxshare Precision Industry (Ma'anshan) Co., Ltd. The transfer price is 110 million yuan (including 13% value-added tax).
This transaction is beneficial for the company to focus on core business development and further optimize the asset structure. The expected impact of this transaction on the company's profit and loss is estimated to be -13 million yuan, subject to confirmation by the company's annual auditing firm.
Related Articles

Infotmic Co., Ltd. shareholder Orient intends to reduce its shareholding by no more than 3%.

US Stock Market Move | Palantir (PLTR.US) fell more than 6.7% in response to its impressive Q3 financial report, but the market is concerned that its valuation is too high.

US Stock Market Move | Royal Philips N.V. Sponsored ADR (PHG.US) rises 3% in Q3, adjusted EBITA exceeds expectations.
Infotmic Co., Ltd. shareholder Orient intends to reduce its shareholding by no more than 3%.

US Stock Market Move | Palantir (PLTR.US) fell more than 6.7% in response to its impressive Q3 financial report, but the market is concerned that its valuation is too high.

US Stock Market Move | Royal Philips N.V. Sponsored ADR (PHG.US) rises 3% in Q3, adjusted EBITA exceeds expectations.

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


